Back to search results

Immune Modulation by Exosomes in COVID-19

Abroad (travel likely)Recruiting

Conditions

COVID-19 · Critical Illness · Hypercytokinemia · Lung Fibrosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Ulm University Hospital, Clinic of Anesthesiology and Intensive Care Medicine, Ulm, Germany

    Contact: Study coordinator (Manfred Weiss, MD, MBA) · manfred.weiss@uniklinik-ulm.de · +49-(0)731-500-60226
    Contact: Study coordinator (Marion Schneider, PhD) · marion.schneider@uni-ulm.de · +49-(0)731-500-60080
    Contact: Principal Investigator (Manfred Weiss, MD)
    Contact: Principal Investigator (Marion Schneider, PhD)
    Bettina Jungwirth, MD (Sub-investigator)
    Karl Traeger, MD (Sub-investigator)
    Eberhard Barth, MD (Sub-investigator)
    Contact: Principal Investigator (Benedikt Nussbaum, MD)
Study leads

  • Manfred Weiss, MD

    Principal Investigator

    Clinic of Anaesthesiology and Intensive Care Medicine

  • Marion Schneider, PhD

    Principal Investigator

    Clinic of Anaesthesiology and Intensive Care Medicine

View source on ClinicalTrials.gov(opens in a new tab)